Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 DKK)

NET PROFIT (x1000 DKK)

EMPLOYEES

Share

Adesso BioProducts AB

Closing information (x1000 DKK)

Closing information 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Turnover 1,788,602 More Arrow 1,822,902 Less Arrow 1,819,243
Financial expenses 11,155 Less Arrow 7,361 More Arrow 8,120
Earnings before taxes 138,450 Less Arrow 112,064 More Arrow 127,045
EBITDA 146,206 Less Arrow 120,180 More Arrow 136,216
Total assets 555,950 More Arrow 603,073 Less Arrow 597,414
Current assets 544,629 More Arrow 591,195 Less Arrow 584,422
Current liabilities 163,656 More Arrow 216,886 More Arrow 267,866
Equity capital 338,560 Less Arrow 296,242 Less Arrow 231,676
- share capital 67 Equal arrow 67 More Arrow 73
Employees (average) 24 Less Arrow 21 Equal arrow 21

Financial ratios

Fiscal year 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Solvency 60.9% Less Arrow 49.1% Less Arrow 38.8%
Turnover per employee 74,525 More Arrow 86,805 Less Arrow 86,631
Profit as a percentage of turnover 7.7% Less Arrow 6.1% More Arrow 7.0%
Return on assets (ROA) 26.9% Less Arrow 19.8% More Arrow 22.6%
Current ratio 332.8% Less Arrow 272.6% Less Arrow 218.2%
Return on equity (ROE) 40.9% Less Arrow 37.8% More Arrow 54.8%
Change turnover -43,688 More Arrow 151,019 More Arrow 430,255
Change turnover % -2% More Arrow 9% More Arrow 31%
Chg. No. of employees 3 Less Arrow 0 More Arrow 1
Chg. No. of employees % 14% Less Arrow 0% More Arrow 5%

Total value of public sale

Fiscal year 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.